Seqens Seqens

X

Find Radio Compass News for Cefepime

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
196
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

Canada

Canada

0

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

https://www.pharmaceutical-technology.com/news/uk-mhra-advanz-pharma-antibiotic/

PHARMACEUTICAL TECHNOLOGY
05 Apr 2024

https://www.fiercepharma.com/pharma/one-one-down-allecra-scores-fda-nod-antibiotic-combo-after-venatorx-hit-crl

FIERCE PHARMA
27 Feb 2024

https://www.businesswire.com/news/home/20240223169844/en

BUSINESSWIRE
23 Feb 2024

https://www.businesswire.com/news/home/20240220917017/en

BUSINESSWIRE
20 Feb 2024

https://www.businesswire.com/news/home/20240109280483/en

BUSINESSWIRE
09 Jan 2024

https://www.prnewswire.com/news-releases/everest-medicines-announces-china-center-for-drug-evaluation-of-nmpa-recommends-priority-review-for-cefepime-taniborbactam-for-the-treatment-of-complicated-urinary-tract-infections-including-pyelonephritis-301932731.html

PR NEWSWIRE
19 Sep 2023

https://www.businesswire.com/news/home/20230815163087/en

BUSINESSWIRE
15 Aug 2023

https://www.prnewswire.com/news-releases/everest-medicines-partner-venatorx-receives-fda-acceptance-and-priority-review-of-new-drug-application-for-cefepime-taniborbactam-to-treat-complicated-urinary-tract-infections-cuti-301900949.html

PR NEWSWIRE
15 Aug 2023

https://www.businesswire.com/news/home/20230627396707/en

BUSINESSWIRE
27 Jun 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-24-2023-89772.pdf

FDA
24 May 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf

FDA
22 Feb 2023

https://www.businesswire.com/news/home/20221020005315/en

BUSINESSWIRE
20 Oct 2022

https://www.businesswire.com/news/home/20221005005413/en

BUSINESSWIRE
05 Oct 2022

https://www.prnewswire.com/news-releases/everest-medicines-announces-that-licensing-partner-venatorx-pharmaceuticals-reports-positive-results-from-pivotal-phase-3-cefepime-taniborbactam-trial-301499929.html

PRNEWSWIRE
10 Mar 2022

https://www.biospace.com/article/releases/allecra-therapeutics-and-advanz-pharma-sign-exclusive-license-and-supply-agreement-for-allecra-s-antibiotic-cefepime-enmetazobactam-in-europe/

BIOSPACE
12 Jan 2022

https://www.businesswire.com/news/home/20210817005672/en

BUSINESSWIRE
17 Aug 2021

https://www.businesswire.com/news/home/20201021005639/en/Venatorx-Pharmaceuticals-to-Present-Data-on-Cefepime-Taniborbactam-at-IDWeek-2020

BUSINESSWIRE
21 Oct 2020

https://finance.yahoo.com/news/venatorx-pharmaceuticals-gardp-partner-develop-040100861.html

YAHOO
29 Apr 2020

https://www.businesswire.com/news/home/20200428006105/en

BUSINESSWIRE
28 Apr 2020

http://www.pharmabiz.com/NewsDetails.aspx?aid=117905&sid=2

PHARMABIZ
03 Sep 2019

https://www.pharmacompass.com/pdf/news/hospira-healthcare-india-pvt-ltd-on-fda-import-alert-list-1549480434.pdf

FDA
01 Aug 2018

http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0343-2015&w=01282015&lang=eng

FDA
28 Jan 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY